Clinical Trial Update: An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 study evaluating the efficacy and safety of Etrumadenant-based treatment combinations in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Etrumadenant (etrumadenant)

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED